Congratulations and welcome to our 2025-2026 residency intern class! We are so excited to welcome this diverse and fantastic group of trainees who are among the best of the best. The Adult Neurology cohort will begin its PGY1 Preliminary Medicine year in July 2025 and its PGY2 Neurology training in July 2026. The Pediatric Neurology […]
As aging bodies decline, the brain loses the ability to cleanse itself of waste, a scenario that scientists think could be contributing to neurodegenerative conditions such as Alzheimer’s disease and Parkinson’s disease, among others. Now, researchers at Washington University School of Medicine in St. Louis report they have found a way around that problem by […]
The research led by Washington University in St. Louis involves families that pass down rare gene mutations almost guaranteeing they’ll develop symptoms at the same age their affected relatives did – information that helps scientists tell if treatments are having any effect. The new findings center on a subset of 22 participants who received amyloid-removing […]
An experimental drug appears to reduce the risk of Alzheimer’s-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a study led by the Knight Family Dominantly Inherited Alzheimer Network-Trials Unit (DIAN-TU), which is based at Washington University School of Medicine in St. Louis. The […]
In January, the FDA banned the use of Red Dye No. 3 in foods and drugs because high concentrations of the dye were shown to cause cancer in rats. In this Living Well, First Alert 4’s Taylor Holt sits down with a local doctor to dig into the ban, find out what’s next and what […]
Eight years after receiving a life-shattering diagnosis, a New Jersey mother credits an “amazing” new drug for stopping her disease in its tracks. Raziel Green, 52, an active runner and mother of two, was diagnosed with a rare form of ALS in 2017.
Congratulations to the members of the Department of Neurology who received accolades through the Supporting a Fair Environment (SAFE) program! SAFE aims to improve the learning environment by promoting positive behaviors and managing concerns about learner mistreatment and unprofessional behaviors. SAFE accolades include treating others with dignity and respect, creating an environment that values diversity, […]
Washington University School of Medicine in St. Louis has received a three-year, $4.5 million grant from the Carol and Gene Ludwig Family Foundation, aimed at advancing research on neuroimmunology and neurodegeneration with the ultimate goal of developing new treatments for Alzheimer’s disease. Administered by WashU Medicine’s Brain Immunology & Glia (BIG) Center, the Carol and […]
Xing “Cathy” Dai, MD, is the newest member of the Adult Neurology Residency Program leadership team at Washington University School of Medicine in St. Louis. She will join Salim Chahin, MD, MSCE, Renee Van Stavern, MD, and Gregory Wu, MD, PhD, as an associate program director, starting July 1, 2025. She began transitioning into the […]
Protein accumulations do important work in the human body, but something can go wrong and proliferate in those aggregates, resulting in neurodegeneration and diseases such as Parkinson’s and Alzheimer’s. One such assembly, amyloid beta peptide, is synonymous with dementia, but researchers were not certain how these peptide assemblies “break bad” and what really causes them […]
Notifications